Shankar Musunuri sold $500k of OCGN
Chief Executive Officer at Ocugen, Inc.. 525,991 shares at an average of $0.95, traded Oct 9, 2026, filed Oct 14, 2026.
Score components
This filing reached EDGAR on Oct 14, 2026, so its score and components open to free visitors on Oct 21, 2026. The trade itself, the rows in the filing and the price context are public now.
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-065797, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | SOpen-market sale Common Stock10b5-1 | -468,727 | $0.95 | $445k | 4,018,470 | 15 h ago |
| Oct 9, 2026 | SOpen-market sale Common Stockindirect: By: KVM Holdings, LLC10b5-1 | -57,264 | $0.95 | $54k | 1,030,771 | 15 h ago |
Related signals
Other insiders at Ocugen, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $589k 525,991 shares | -11% | |
| 35Weak | OCGNbuy Ocugen, Inc. | Treerita Essalima Johnson-Greene Chief Financial Officer | $26k 21,000 shares | +4% | |
| 31Weak | Ocugen, Inc. | Prabhavathi Fernandes director | $9,095 10,000 shares | - | |
| 33Weak | Ocugen, Inc. | Kirsten Castillo director | $23k 25,000 shares | +50% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.